FDA Warns Fresenius About Leaking PD Solution Bags and Particulates

The letter states it “summarizes significant violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals.” The letter asked for assessment and remediation plans to resolve the violations, recommended engaging a consultant, and required prompt correction of the violations.

Read the full article » | Posted 09-18-2026

Related Articles